Factor V inhibitors: Rare or not so uncommon? A multi-laboratory investigation

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 8, 2004, Pages 637-647

  Favaloro, Emmanuel J ^a   Posen, Jennifer ^b   Ramakrishna, Raj ^c   Soltani, Soma ^a   McRae, Simon ^d   Just, Sarah ^e   Aboud, Margaret ^f   Low, Joyce ^g   Gemmell, Rosalie ^h   Kershaw, Geoff ⁱ   Coleman, Robyn ^j   Dean, Mark ^k  

^a WESTMEAD HOSPITAL   (Australia)

^b SYDNEY ADVENTIST HOSPITAL   (Australia)

^c Illawarra Medical Laboratories   (Australia)

^d NEWCASTLE MATER HOSPITAL   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h ST GEORGE HOSPITAL   (Australia)

ⁱ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^j SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^k GOSFORD HOSPITAL   (Australia)

more..

Author keywords

Anti cardiolipin antibody; Anti phospholipid antibody; Factor V inhibitor; Lupus anticoagulant

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 5; PHOSPHOLIPID ANTIBODY; THROMBIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CATTLE; FACTOR V DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; THROMBIN;

EID: 10044252189     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200412000-00003     Document Type: Article

References (29)

1. Macik BG, Crow P. Acquired autoantibodies to coagulation factors. Curr Opin Hematol 1999; 6:323-328.
2. Wright J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9:418-435.
3. Green D. Spontaneous inhibitors to coagulation factors. Clin Lab Haematol 2000; 22(suppl 1):21-25.
4. Knobl P, Lechner K. Acquired factor V inhibitors. Bailliere's Clin Haematol 1998; 11:305-318.
5. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002; 42:18-26.
6. Kasper CK. Laboratory diagnosis of factor VIII inhibitors. In: Kessler C (editor): Acquired haemophilia, second edition. Princeton, NJ: Medica; 1995, pp. 9-24.
7. Mohammed A, Mehrabani PA, Coombs R, Molesworth L, Favaloro EJ. The MDA-180 Coagulation Analyser: A laboratory evaluation. Pathology 1997; 29:176-183.
8. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79:678-682.
9. Wong RCW, Favaloro EJ, Pollock W, Wilson RJ, Hendle MJ, Adelstein S, et al. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology 2004; 36:182-192.
10. Miesbach W, Voigt J, Peetz D, Scharrer I. Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin [In German]. Med Klin (Munich) 2003; 98:339-343.
11. Caers J, Reekmans A, Jochmans K, Naegels S, Mana F, Urbain D, Reynaert H. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer. Endoscopy 2003; 35:542-544.
12. Okoshi Y, Akiyama H, Inoue T, Koyama T, Kono N, Matsumura T, et al. A long-lasting idiopathic factor V inhibitor [In Japanese]. Rinsho Ketsueki 2003; 44:14-18.
13. Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis 2003; 14: 87-93.
14. de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am J Hematol 2003; 74:187-190.
15. Hasegawa M, Tanaka T, Kii T, Fujiwara S, Ikeda N, Kinntaka D, et al. Acquired inhibitor against coagulation factor V with severe hematuria [In Japanese]. Rinsho Ketsueki 2003; 44:933-939.
16. Ajzner E, Balogh I, Haramura G, Boda Z, Kalmar K, Pfliegler G, et al. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J Thromb Haemost 2003; 1: 943-949.
17. Iino N, Maruyama H, Gejyo F. Acquired coagulation abnormality due to factor V inhibitor [In Japanese]. Nippon Naika Gakkai Zasshi 2002; 91:3295-3297.
18. Otawa M, Gotoh A, Miyazawa K, Fukutake K, Ohyashiki K. Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis [In Japanese], Rinsho Ketsueki 2002; 43:1050-1054.
19. Bayani N, Rugina M, Haddad-Vergnes L, Lelong F. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. Am J Hematol 2002; 71:33-36.
20. Neschis DG, Heyman MR, Cheanvechai V, Benjamin ME, Flinn WR. Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. J Vasc Surg 2002; 35:400-402.
21. Kyriakou DS, Alexandrakis MG, Passam FH, Foundouli K, Matalliotakis E, Koutroubakis IE, et al. Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 2002; 14:1383-1387.
22. Emori Y, Sakugawa M, Niiya K, Kiguchi T, Kojima K, Takenaka K, et al. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis 2002; 13: 555-559.
23. Kalafatis M, Simioni P, Tormene D, Beck DO, Luni S, Girolami A. Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood 2002; 99:3985-3992.
24. Shastri KA, Ho C, Logue G. An acquired factor V inhibitor: clinical and laboratory features. J Med 1999; 30:357-366.
25. McGlasson DL, Mercier DL, Potempa LF, Patterson WR. Platelet- neutralization procedure: atypical results seen with factor V deficiency with and without an inhibitor. Clin Lab Sci 1990; 3:119-121.
26. Kapur A, Kelsey P, Isaacs P. Factor V inhibitor in thrombosis. Am J Haematol 1993; 42:384-388.
27. Kamphuisen P, Haan J, Rosekrans P, Van Der Meer F. Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features. Am J Haematol 1998; 57:176-178.
28. Izumi T, Kim SW, Greist A, Macedo-Ribeiro S, Fuentes-Prior P, Bode W, et al. Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding. Thromb Haemost 2001; 85:1048-1054.
29. Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med 1999; 133:326-334.